Generics

Innovative Products found!

Biosimilars

Medical devices

Nutraceuticals

Filters

Pp-174 manufacturers

Filters

Filters

Filters , active

Country of origin : Taiwan
1 products found

pp-174

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
Taiwan
GMP approvals
Taiwan
Comments
Indication: Influenza A and B — acute uncomplicated influenza in adults and adolescents Clinical stage: Phase 3 — ongoing Modality: Small molecule Mechanism / Target: Cap-dependent endonuclease (CEN) inhibitor — blocks viral RNA polymerase cap-snatching step required for viral mRNA transcription; same mechanism as baloxavir but structurally distinct Route / form: Oral tablet (potential single-dose or short course) Differentiation: Novel CEN inhibitor independent from oseltamivir's neuraminidase mechanism; structurally distinct from baloxavir; potential single-dose convenience; lower resistance risk than neuraminidase inhibitors
Manufacturer #8794

Clinical-stage biotechnology company developing anti-infective and oncology therapeutics. Focuses on single-dose or short-course antiviral agents for influenza and bacterial infections. Wholly owned Phase 3 anti-influenza programme advancing in Asia.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.